Andrulis Pharmaceuticals Report issue

For profit Phase 2
Founded: Baltimore MD United States (1990)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
1999
NCT00000790
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

thalidomide (Thalomid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

Communicable Diseases (Phase 2)

HIV Infections (Phase 2)

Infections (Phase 2)

Stomatitis (Phase 2)

Stomatitis, Aphthous (Phase 2)

Viremia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1